{"url":"https://whatshealthyandwhy.com/long-covid/natural-support","path":"/long-covid/natural-support","alternates":{"json":"https://whatshealthyandwhy.com/api/articles/long-covid/natural-support.json","markdown":"https://whatshealthyandwhy.com/long-covid/natural-support.md"},"topic":{"slug":"long-covid","name":"Long COVID","url":"https://whatshealthyandwhy.com/long-covid"},"slug":"natural-support","order":1,"title":"Natural Support","question":"Can supplements and diet help with long COVID symptoms?","answer":"NAC and omega-3 may ease some long COVID symptoms, and low vitamin D is linked to worse outcomes, but evidence is small and non-randomized.","description":"Evidence-based nutritional and lifestyle approaches for post-acute COVID-19 sequelae, addressing oxidative stress, gut dysbiosis, persistent inflammation, and mitochondrial recovery","confidence":2,"confidenceNote":"Evidence: one 9-person retrospective NAC study plus observational studies of omega-3 (33,908 patients), vitamin D and gut bacteria.","evidenceSummary":{"rctCount":0,"observationalCount":4,"metaAnalysisCount":0,"totalParticipants":"6 million+","replicated":false,"newestStudyYear":2025},"category":{"categoryTitle":"Your Body","categorySlug":"your-body","subcategoryName":"Body Systems","subcategorySlug":"systems","url":"https://whatshealthyandwhy.com/explore/your-body/systems"},"actions":["Pace yourself: stay below your symptom threshold and avoid vigorous exercise early on, because overexertion can worsen post-exertional malaise.","Ask your doctor to test vitamin D before supplementing; deficiency was linked to more post-acute emergency visits [5].","Eat diverse plant fibres and a daily fermented food such as kefir, yogurt or sauerkraut to rebuild gut bacteria depleted in long COVID [2]."],"cautions":["Use these steps alongside medical care, and seek a doctor's assessment for breathlessness, palpitations or symptoms that worsen.","Get vitamin D tested before high-dose supplementing to avoid over-correction [5].","Omega-3 did not improve fatigue or brain fog in a 33,908-patient analysis, and the NAC study was small, retrospective, non-randomized and in cancer patients [3][4]."],"simpleText":"Long COVID — formally called post-acute sequelae of SARS-CoV-2 (PASC) — refers to symptoms that persist or emerge weeks to months after acute infection has resolved. The most common complaints are profound fatigue, brain fog, breathlessness, and post-exertional malaise: a worsening of symptoms after physical or mental effort that can set recovery back significantly [1]. A large 2-year follow-up of nearly 140,000 individuals showed that risk for most post-acute symptoms attenuated over time in people who were not hospitalised, though full resolution is not guaranteed [1]. Overlapping biological mechanisms — oxidative stress, gut dysbiosis, persistent low-grade inflammation, and vitamin D insufficiency — suggest that targeted nutritional and lifestyle support may meaningfully reduce symptom burden alongside medical care [2][3][5].","mediumText":"What Drives Long COVID Symptoms\n\nLong COVID is not a single mechanism but a cluster of overlapping dysfunctions. Four drivers are well-supported by current research and directly inform natural interventions:\n\nOxidative stress and glutathione depletion. SARS-CoV-2 infection depletes glutathione — the body's principal intracellular antioxidant — and generates significant reactive oxygen species. This oxidative burden can persist long after viral clearance and may account for fatigue, breathlessness, and exercise intolerance. Some researchers also implicate microthrombi (tiny clots in capillaries) driven partly by elevated von Willebrand factor, a pro-clotting protein that oxidative stress helps sustain.\n\nGut microbiome disruption. COVID-19 consistently disturbs the gut microbiome, and in patients who develop Long COVID, dysbiosis persists for at least one year after discharge [2]. Beneficial bacteria that produce short-chain fatty acids — including Faecalibacterium prausnitzii and Bifidobacterium species — are significantly depleted. This affects intestinal barrier integrity, immune regulation, and the gut-brain axis, potentially contributing to cognitive symptoms and mood changes.\n\nPersistent low-grade inflammation. Elevated inflammatory cytokines have been measured months post-infection in Long COVID patients, particularly in those with fatigue and cognitive symptoms. Omega-3 fatty acids influence the resolution of inflammation through specialized pro-resolving mediator (SPM) pathways and have been studied specifically in the post-COVID context [4].\n\nVitamin D insufficiency. COVID-19 patients who develop vitamin D deficiency are at elevated risk of adverse post-acute outcomes [5]. Vitamin D is involved in both innate and adaptive immune regulation and modulates the renin-angiotensin system — the same pathway SARS-CoV-2 exploits via the ACE2 receptor.\n\nNAC for Oxidative Stress and Dyspnea\n\nN-acetylcysteine (NAC) is one of the most biologically plausible interventions for Long COVID. It raises intracellular glutathione, reduces oxidative stress and inflammation, and has a property particularly relevant here: it breaks disulfide bonds in von Willebrand factor multimers, potentially helping dissolve microthrombi that contribute to circulatory and respiratory symptoms.\n\nA small retrospective study of Long COVID patients in a gynecologic oncology clinic found that all 3 patients using NAC (600–1200 mg twice daily) reported improved shortness of breath, brain fog and fatigue, with normalization of elevated von Willebrand factor levels, while none of the 6 control patients did [3]. Typical supplemental dosing ranges from 600–1800 mg/day in divided doses, taken with food to reduce gastrointestinal upset. NAC is widely available as an over-the-counter supplement and has a well-established safety record at these doses.\n\nSee our NAC page for more on its mechanisms and applications.\n\nGut Restoration: Probiotics, Fermented Foods, and Prebiotic Fiber\n\nRestoring the microbiome is one of the most tangible targets for Long COVID support. Multi-strain probiotics containing Bifidobacterium longum and Lactobacillus species are a practical starting point, particularly strains among those consistently depleted in Long COVID patients [2].\n\nDietary strategies matter equally. Fermented foods — kefir, kimchi, yogurt, sauerkraut, tempeh — deliver live cultures alongside fermentation metabolites. Prebiotic fiber from Jerusalem artichoke, chicory root, garlic, leeks, and oats feeds the beneficial bacteria that need to re-establish. Butyrate, a short-chain fatty acid produced by microbes fermenting fiber, provides fuel for colonocytes and helps restore gut barrier integrity. A diet rich in diverse plant fibers with daily fermented food intake is one of the most evidence-consistent approaches to rebuilding microbial diversity.\n\nSee our gut microbiome page and fermented foods overview for more.\n\nOmega-3 Fatty Acids for Inflammation Resolution\n\nA large retrospective study of 33,908 COVID-19 patients found omega-3 use was associated with lower rates of post-COVID cough and myalgia, though effects on brain fog and fatigue were not statistically significant in this analysis [4]. While omega-3 alone is unlikely to resolve Long COVID's cognitive burden, its anti-inflammatory and pro-resolving mechanisms remain relevant in the setting of sustained systemic inflammation.\n\nEPA and DHA at 2–4 g/day total — from fish oil or algal oil — represent the best-studied forms. Taking omega-3 with the largest meal of the day reduces the aftertaste associated with some products and improves absorption. Phospholipid-bound omega-3 (krill oil) may offer superior uptake for some individuals.\n\nVitamin D Assessment and Correction\n\nGiven the demonstrated association between post-acute vitamin D deficiency and worse outcomes, testing serum 25-hydroxyvitamin D levels is a practical early step for anyone with Long COVID [5]. Most integrative clinicians target 50–80 ng/mL (125–200 nmol/L). Vitamin D3 at 2000–5000 IU daily alongside vitamin K2 (100–200 mcg MK-7) supports optimal utilization and prevents inappropriate calcium deposition. Testing is essential before high-dose supplementation to avoid over-correction.\n\nPacing and Nervous System Support\n\nPost-exertional malaise — symptom worsening after exertion that exceeds a person's current capacity — is a hallmark of Long COVID that distinguishes it from simple deconditioning. Vigorous exercise and aggressive rehabilitation can worsen this condition, particularly in the first months. Pacing — deliberately staying below the symptomatic threshold — is consistently recommended by specialist clinics.\n\nMany Long COVID patients also experience dysautonomia (autonomic dysfunction): heart palpitations, orthostatic intolerance, and difficulty regulating temperature. Vagal nerve support is practical here: slow diaphragmatic breathing (extending the exhale to 6–8 seconds), gentle yoga, and cold water splashed on the face activate the parasympathetic brake on the sympathetic nervous system. See our vagus nerve page for techniques with published evidence.\n\nAdditional considerations: magnesium glycinate (300–400 mg at night) supports sleep and muscle recovery; CoQ10 (200–400 mg/day) supports mitochondrial energy production; and adequate protein intake (1.2–1.6 g/kg body weight) preserves muscle during a period when activity may be limited.","deepText":"Evidence Review\n\nLong-Term Trajectory: Nature Medicine Cohort\n\nBowe et al. (2023) followed 138,818 individuals with confirmed SARS-CoV-2 infection alongside 5,985,227 non-infected controls from the US Department of Veterans Affairs database for two years, systematically comparing risks for 80 pre-specified post-acute sequelae [1]. By two years, risks in non-hospitalised individuals had largely attenuated toward baseline for most outcomes, though fatigue, respiratory, and cognitive symptoms remained modestly elevated. In hospitalised individuals, elevated risk persisted across multiple organ systems — cardiovascular, pulmonary, and neurological — throughout the two-year follow-up.\n\nThe study provides crucial epidemiological context: Long COVID trajectory is heavily dependent on acute illness severity. Non-hospitalised patients have better recovery prospects, while those with severe initial illness face more durable sequelae. Important limitations: the cohort was predominantly older male veterans, which may not represent younger, female, or otherwise healthier populations who represent a large proportion of Long COVID cases in the general community.\n\nGut Microbiome Dysbiosis at One Year\n\nZhang et al. (2023) enrolled 187 recovered COVID-19 patients alongside 30 healthy controls, performing 16S rRNA gene sequencing of stool samples at one year post-discharge [2]. Of the recovered patients, 84 (44.9%) reported persistent Long COVID symptoms. Symptomatic patients showed significantly reduced alpha-diversity (Shannon index) compared to both asymptomatic recovered patients and healthy controls.\n\nSpecifically, Long COVID patients showed depletion of Faecalibacterium prausnitzii, Roseburia intestinalis, and Bifidobacterium species — all short-chain fatty acid producers — alongside enrichment of potentially pathogenic taxa including Ruminococcus gnavus and Bacteroides vulgatus. Stool butyrate concentrations correlated inversely with symptom severity scores. Limitations include the relatively small sample, single-center Chinese hospital design, and that 16S rRNA methodology identifies taxa without strain-level resolution. These findings are nonetheless consistent with multiple independent microbiome studies in Long COVID patients, increasing confidence that gut dysbiosis is a real and persistent feature of the condition rather than an artifact.\n\nNAC for Dyspnea and Vascular Markers\n\nBellone et al. (2025) retrospectively evaluated 9 Long COVID/PASC patients followed in a gynecologic oncology clinic, all with persistent symptoms and elevated von Willebrand factor (vWF) levels: 3 reported regular NAC use (600–1200 mg twice daily) and 6 were controls [3]. All 3 NAC users had subjective improvement in shortness of breath, brain fog and fatigue with normalization of vWF levels, versus none of the control patients (Fisher's exact P = 0.0119).\n\nThe authors note that persistent microvascular inflammation causing chronically elevated von Willebrand factor and other clotting factors may be at the root of Long COVID symptoms, and describe NAC as having mucolytic, antioxidant, anti-inflammatory and thrombolytic properties. Key limitations: this was a small, retrospective, non-randomized study in a cancer patient population, which substantially limits generalizability to the general Long COVID population. Cancer and its treatment independently affect oxidative stress and coagulation markers. A randomized, placebo-controlled trial in a general Long COVID cohort is needed to confirm the vWF normalization finding.\n\nOmega-3 and Post-Acute Psychiatric and Somatic Sequelae\n\nLiu et al. (2023) conducted a retrospective cohort analysis of 33,908 COVID-19 patients from a large US electronic health records database, comparing those with documented omega-3 prescription use versus non-users over one year [4]. Omega-3 use was associated with statistically significant reductions in post-COVID cough (odds ratio 0.71, 95% CI 0.57–0.88) and myalgia (OR 0.75, 95% CI 0.58–0.97). However, no significant associations were found for fatigue, headache, or cognitive symptoms.\n\nThe study is notable for its large size, but inherits the limitations of retrospective pharmacy record analysis: omega-3 dosing was not standardized, prescription-based omega-3 (typically at very high doses for hypertriglyceridemia) may differ in effect from lower-dose OTC supplementation, and confounding by health-conscious behavior is difficult to fully exclude. The null finding for brain fog and fatigue indicates that omega-3 supplementation alone, at typical doses, is likely insufficient as a primary cognitive intervention in Long COVID — even as its anti-inflammatory properties may provide modest benefit for systemic symptoms.\n\nVitamin D Deficiency and Post-Acute Outcomes\n\nWu et al. (2024) examined post-acute outcomes in COVID-19 patients stratified by vitamin D status, drawing on data from a multicenter Taiwanese cohort [5]. COVID-19 patients with vitamin D deficiency (< 20 ng/mL) had a 1.41-fold higher risk of all-cause emergency department visits during the post-acute phase (HR 1.41, 95% CI 1.09–1.82), independent of age, sex, comorbidities, and vaccination status. Trends toward higher hospitalization were observed but did not reach statistical significance.\n\nThis association does not prove causality — vitamin D deficiency may be a marker of poor overall health or limited sun exposure rather than a direct modifiable driver of Long COVID severity. However, given the low cost, the good safety profile of correcting deficiency to normal range, and vitamin D's established roles in immune modulation and ACE2 expression regulation, supplementation to normalize levels represents a reasonable and practical low-risk intervention for Long COVID patients with confirmed insufficiency.","deepTruncated":false,"references":[{"id":"1","title":"Postacute sequelae of COVID-19 at 2 years","authors":"Bowe B, Xie Y, Al-Aly Z","year":2023,"journal":"Nature Medicine","pmid":"37605079","url":"https://pubmed.ncbi.nlm.nih.gov/37605079/"},{"id":"2","title":"Gut Microbiota Dysbiosis Correlates With Long COVID-19 at One-Year After Discharge","authors":"Zhang D, Zhou Y, Ma Y, Chen P, Tang J, Yang B","year":2023,"journal":"Journal of Korean Medical Science","pmid":"37069814","url":"https://pubmed.ncbi.nlm.nih.gov/37069814/"},{"id":"3","title":"N-acetylcysteine (NAC) supplementation improves dyspnea and may normalize von Willebrand plasma levels in gynecologic patients with Post-Acute-COVID-Sequela (PASC)/Long COVID","authors":"Bellone S, Siegel ER, Santin AD","year":2025,"journal":"Gynecologic Oncology Reports","pmid":"39944180","url":"https://pubmed.ncbi.nlm.nih.gov/39944180/"},{"id":"4","title":"Omega-3 polyunsaturated fatty acids and the psychiatric post-acute sequelae of COVID-19: A one-year retrospective cohort analysis of 33,908 patients","authors":"Liu TH, Ho CH, Chen DT, Wu JY, Huang PY, Lai CC","year":2023,"journal":"Brain, Behavior, and Immunity","pmid":"37716377","url":"https://pubmed.ncbi.nlm.nih.gov/37716377/"},{"id":"5","title":"Association between vitamin D deficiency and post-acute outcomes of SARS-CoV-2 infection","authors":"Wu JY, Liu MY, Hsu WH, Tsai YW, Liu TH, Huang PY","year":2024,"journal":"European Journal of Nutrition","pmid":"38112761","url":"https://pubmed.ncbi.nlm.nih.gov/38112761/"}],"wordCount":1767,"source":{"path":"src/content/topics/long-covid/natural-support.md"},"citeAs":"“Can supplements and diet help with long COVID symptoms?.” What's Healthy and Why. https://whatshealthyandwhy.com/long-covid/natural-support","notice":"General information backed by peer-reviewed research, not medical advice."}